A phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel in older patients with metastatic HER2 positive breast cancer (JCOG1607 HERB TEA study)
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as rst line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
Key abstracts/publications in HER2+ve Breast Cancer
Chairpersons :
Dr. Shyam Agrawal, Dr. S D Banavali
Speaker :
Dr. Prabhat Bhargava